Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

Details for Australian Patent Application No. 2002339845 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 60/309,516 03.08.01 US

29 May 2003 Application Open to Public Inspection

Published as AU-B-2002339845

23 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

6 April 2006 Corrigenda

Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2002 Delete all reference to Application No. 2002339845

26 March 2009 Application Accepted

Published as AU-B-2002339845

23 July 2009 Standard Patent Sealed

6 September 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Roche GlycArt AG . Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.